Read more

August 17, 2022
1 min read
Save

Shared decision-making tool may reduce opioid use after hand surgery

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Use of a shared decision-making tool during hand surgery may yield equivalent or better pain control and reduce the number of opioids prescribed, according to published results.

Perspective from Jeffrey G. Stepan, MD, MSc

“Shared decision-making tools have an important role in educating patients about their orthopedic perioperative care,” Rajshri M. Bolson, MD, FAAOS, assistant chief of surgery at VA Eastern Colorado Health Care, told Healio. “Our study showed that a simple but effective educational tool used as part of the shared decision-making model could reduce opioid prescribing without compromising pain control after surgery.”

OT0722Bolson_Graphic_01
Results showed patients who had access to a shared decision-making tool after hand surgery received an average of 6.4 oxycodone pills vs. 10 oxycodone pills for patients who did not have access to the tool. Data were derived from Bolson R, et al. J Hand Surg Glob Online. 2022;doi:10.1016/j.jhsg.2022.05.003.

Bolson and colleagues randomly assigned 53 patients undergoing outpatient carpal tunnel release, trigger finger release or ganglion cyst excision to either use an educational, shared decision-making tool that presented information on postoperative pain, opioids and alternative modalities of treatment (shared tool group; n=25) or to receive a survey only (no tool group; n=28). Researchers surveyed patients for 4 weeks after surgery, which included patient-reported outcome measurement information system pain intensity and pain interference scores, as well as the number of oxycodone or over-the-counter pills taken.

Rajshri M. Bolson
Rajshri M. Bolson

Results showed patients in the shared tool group received an average of 6.4 oxycodone pills vs. an average of 10 oxycodone pills for patients in the no tool group. Researchers found patients in the shared tool group and no tool group took a median of 2 and 3 oxycodone pills in the first week after surgery, respectively. Although patient-reported outcome measures for pain intensity and pain interference were not significantly different for postoperative weeks 1, 3 and 4, researchers noted patients in the shared tool group had a significantly lower pain interference score for postoperative week 2.

“We need to continue to understand what tools are most effective and how to best implement them in practice,” Bolson said. “By taking the time to build these types of tools and make shared decision-making a routine part of our practice, we, as orthopedic surgeons, can make a big impact in optimizing the care of our patients.”